Skip to content
Biodatica
Start free

Universidad Complutense de Madrid

Madrid

Oncologyliquid biopsyGrant-only
Compare Sign in to watch

What changed

Study registered, no phase assigned: Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study.

7w agoTrial registeredMay 26, 2026Source filing (opens the source filing in a new tab)

Momentum

90no change

Momentum 90 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

12,339 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Jan 1, 2025

    Diabetes Complications, Diabetes Education, Diabetes Foot Care · COMPLETED · sponsor: Universidad Complutense de Madrid · Impact of an Educational Intervention on Ulcer Incidence, Knowledge, Self-Care, and Quality of Life in Diabetic Foot Syndrome

    ClinicalTrials.gov · NCT07329491 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Nov 1, 2024

    Xerosis Cutis, Neuropathic Pain Associated With Diabetic Peripheral Neuropathy · COMPLETED · sponsor: Universidad Complutense de Madrid · Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy

    ClinicalTrials.gov · NCT07162454 (opens the source filing in a new tab)

  3. Grant

    P20 · $308k · non-dilutive

    Sep 19, 2023

    UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUGO-MARTINEZ, JOSE · NIGMS · award ends Aug 31, 2028 · Research Core

    NIH RePORTER · NIH RePORTER 11171408 (opens the source filing in a new tab)

  4. Trial

    NA registered

    Jan 1, 2022

    Colorectal Cancer, Liver Metastases, Genetic Change · RECRUITING · sponsor: Hospital Vall d'Hebron · Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

    ClinicalTrials.gov · NCT05398380 (opens the source filing in a new tab)

  5. Trial

    Study registered

    Apr 24, 2020

    Unresectable Cholangiocarcinoma · RECRUITING · sponsor: Hospital Vall d'Hebron · Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Perihilar Cholangiocarcinoma. A Prospective Multicenter Study.

    ClinicalTrials.gov · NCT04378023 (opens the source filing in a new tab)

  6. Grant

    SC3 · $107k · non-dilutive

    Feb 7, 2018

    CALIFORNIA STATE UNIVERSITY FULLERTON · PI RAMIREZ, MARIA SOLEDAD · NIGMS · award ends Jun 30, 2027 · Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter spp

    NIH RePORTER · NIH RePORTER 11111361 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources